The company has expressed confidence in completing the remaining requirements in the full approval process and it anticipates commercial U.S. availability of Mobi-C in 2013.
More Articles on Orthopedic Devices:
Alphatec Spine 3Q Revenue Drops 1.6%
Amedica Names Jay Moyes to Board of Directors
Globus Medical 3Q Worldwide Sales Reach $94.8M, Up 12.5%



